Pan-Cancer Analysis of KANK2: Clinical and Molecular Insights into Tumor Progression and Therapeutic Implications
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The KANK2 gene is a valuable biomarker for diagnosing and predicting outcomes in multiple cancers. Its expression correlates with key cellular processes, suggesting potential as a therapeutic target.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- KANK2 gene is vital for cell migration and movement.
- KANK2 is implicated in various neoplastic and non-neoplastic diseases.
Purpose Of The Study
- To analyze KANK2 gene expression.
- To evaluate its diagnostic and prognostic significance in 33 cancer types.
Main Methods
- Utilized The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases.
- Employed bioinformatics tools (R, Cytoscape, HPA, TISIDB, UALCAN, GEO, cBioPortal, STRING, GSCALite, CancerSEA) and experimental validation (Western Blot, qPCR).
Main Results
- KANK2 shows significant diagnostic value (AUC > 0.75 in 13 cancers) and prognostic association with Overall Survival (OS) and Disease-Specific Survival (DSS).
- Expression patterns correlate with molecular/immune subtypes, genetic mutations, DNA methylation, EMT, angiogenesis, and apoptosis.
- Identified interacting proteins and potential drug targets; findings confirmed by GEO datasets and experimental validation.
Conclusions
- KANK2 is a promising biomarker for cancer diagnosis and prognosis.
- KANK2 expression is linked to critical cancer-related molecular and cellular processes.
- KANK2 represents a potential therapeutic target for future cancer research.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...